CA1202581A
(en)
*
|
1980-03-27 |
1986-04-01 |
Saran A. Narang |
Adaptor molecules for dna and their application to synthesis of gene-derived products
|
GR74498B
(ko)
|
1980-04-03 |
1984-06-28 |
Biogen Inc |
|
US4874702A
(en)
*
|
1980-09-08 |
1989-10-17 |
Biogen, Inc. |
Vectors and methods for making such vectors and for expressive cloned genes
|
DK489481A
(da)
*
|
1980-11-10 |
1982-05-11 |
Searle & Co |
Plasmidvektor og frmgangsmaade til fremstilling deraf
|
US5525484A
(en)
*
|
1981-01-16 |
1996-06-11 |
Genome Therapeutics Corp. |
Recombinant DNA means and method for producing rennin, prorenin and pre-prorennin
|
BR8205954A
(pt)
*
|
1981-10-14 |
1983-09-13 |
Unilever Nv |
Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
|
JPS58110600A
(ja)
*
|
1981-12-25 |
1983-07-01 |
Kyowa Hakko Kogyo Co Ltd |
ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
|
JPS58141796A
(ja)
*
|
1982-02-18 |
1983-08-23 |
Kyowa Hakko Kogyo Co Ltd |
ペプチドの製造法
|
ATE64618T1
(de)
*
|
1982-03-15 |
1991-07-15 |
Schering Corp |
Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
|
US4499188A
(en)
*
|
1982-05-05 |
1985-02-12 |
Cetus Corporation |
Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator
|
US4863855A
(en)
*
|
1982-05-14 |
1989-09-05 |
The Research Foundation Of State University Of New York |
Novel cloning vehicles for polypeptide expression in microbial hosts
|
DE3378638D1
(de)
*
|
1982-10-25 |
1989-01-12 |
Monsanto Co |
Reca promoter dependent polypeptide production
|
IE56509B1
(en)
*
|
1982-11-04 |
1991-08-28 |
Univ California |
Methods for oncogenic detection
|
DE3247922A1
(de)
*
|
1982-12-24 |
1984-06-28 |
Boehringer Ingelheim International GmbH, 6507 Ingelheim |
Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
|
US5169762A
(en)
*
|
1983-03-03 |
1992-12-08 |
Genentech, Inc. |
Human nerve growth factor by recombinant technology
|
DK161152C
(da)
|
1983-03-03 |
1991-11-11 |
Genentech Inc |
Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
|
US4701416A
(en)
*
|
1983-12-09 |
1987-10-20 |
Cetus Corporation |
Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
|
US4935370A
(en)
*
|
1983-12-23 |
1990-06-19 |
Pfizer Inc. |
Expression plasmids for improved production of heterologous protein in bacteria
|
JP2595205B2
(ja)
*
|
1984-02-08 |
1997-04-02 |
カロイン コーポレイション |
発現カセット
|
GB8407044D0
(en)
*
|
1984-03-19 |
1984-04-26 |
Fujisawa Pharmaceutical Co |
Producing human insulin
|
US5028531A
(en)
*
|
1984-03-19 |
1991-07-02 |
Fujisawa Pharmaceutical Company, Ltd. |
IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
|
US4656132A
(en)
*
|
1984-03-28 |
1987-04-07 |
Cetus Corporation |
Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
|
US4894334A
(en)
*
|
1984-03-28 |
1990-01-16 |
Cetus Corporation |
Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
|
US5268278A
(en)
*
|
1984-03-30 |
1993-12-07 |
Istituto Farmacologico Serono S.P.A. |
Genetic expression of somatostatin as hybrid polypeptide
|
US4789702A
(en)
*
|
1984-05-18 |
1988-12-06 |
Cetus Corporation |
Feline leukemia virus vaccine
|
US5683688A
(en)
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
JPS619282A
(ja)
*
|
1984-06-22 |
1986-01-16 |
Hitachi Ltd |
遺伝子組換え菌の培養方法
|
EP0165613B1
(en)
*
|
1984-06-22 |
1992-01-15 |
Hitachi, Ltd. |
Process for controlling culture of recombinants
|
JPS6158595A
(ja)
*
|
1984-08-28 |
1986-03-25 |
ジェネックス・コーポレイション |
徴生物によるタンパク質規模生産方法
|
US4738921A
(en)
*
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
US5075224A
(en)
*
|
1984-10-19 |
1991-12-24 |
Genentech, Inc. |
Prepro-LHRH C-terminal peptide DNA
|
NZ213759A
(en)
*
|
1984-10-19 |
1989-01-27 |
Genentech Inc |
Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
|
FI90990C
(fi)
*
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
|
DE3650625T2
(de)
|
1985-01-28 |
1997-10-02 |
Xoma Corp |
AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren
|
IT1234977B
(it)
*
|
1985-03-22 |
1992-06-09 |
Serono Ist Farm |
Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
|
US4683202A
(en)
*
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4965188A
(en)
*
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
ES8706823A1
(es)
*
|
1985-03-28 |
1987-06-16 |
Cetus Corp |
Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra
|
GB8509289D0
(en)
*
|
1985-04-11 |
1985-05-15 |
Fujisawa Pharmaceutical Co |
Production of somatostatin
|
DE3526995A1
(de)
*
|
1985-07-27 |
1987-02-05 |
Hoechst Ag |
Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung
|
ES2000859A6
(es)
*
|
1985-08-12 |
1988-03-16 |
Syntex Inc |
Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
|
AU6104786A
(en)
*
|
1985-08-12 |
1987-02-19 |
Syntex (U.S.A.) Inc. |
Fusion proteins using trple gene
|
JPH0775536B2
(ja)
*
|
1986-03-26 |
1995-08-16 |
猛 小林 |
遺伝子組み換え菌を用いた酵素生産装置
|
DE3642096A1
(de)
*
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
Pferde-(gamma)-interferon
|
US6994988B1
(en)
|
1987-02-12 |
2006-02-07 |
Genetech, Inc. |
Methods and deoxyribonucleic acid for the preparation of tissue factor protein
|
JPH01247099A
(ja)
*
|
1988-03-30 |
1989-10-02 |
Hitachi Ltd |
ヒトの上皮細胞増殖因子の遺伝子工学的生産方法
|
EP0335400B1
(en)
*
|
1988-03-30 |
1994-06-08 |
Hitachi, Ltd. |
Processes for production of human epidermal growth factor by genetic engineering
|
JPH01247098A
(ja)
*
|
1988-03-30 |
1989-10-02 |
Hitachi Ltd |
ヒトの上皮細胞増殖因子の遺伝子工学的生産方法
|
JPH0227993A
(ja)
*
|
1988-07-15 |
1990-01-30 |
Nippon Shinyaku Co Ltd |
hEGFの製法
|
IL92937A0
(en)
|
1989-01-31 |
1990-09-17 |
Us Health |
Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
IE914102A1
(en)
|
1990-11-26 |
1992-06-03 |
Genetics Inst |
Expression of pace in host cells and methods of use thereof
|
AU664469B2
(en)
|
1992-06-03 |
1995-11-16 |
Genentech Inc. |
Tissue plasminogen activator glycosylation variants with improved therapeutic properties
|
GB9325182D0
(en)
*
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
US6001604A
(en)
*
|
1993-12-29 |
1999-12-14 |
Bio-Technology General Corp. |
Refolding of proinsulins without addition of reducing agents
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US6455304B1
(en)
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
US6951743B2
(en)
|
1997-10-31 |
2005-10-04 |
University Of Oklahoma Board Of Regents |
Hyaluronan synthase genes and expression thereof in bacillus hosts
|
US7091008B1
(en)
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
US6113905A
(en)
*
|
1995-01-06 |
2000-09-05 |
The Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US6077510A
(en)
*
|
1995-01-06 |
2000-06-20 |
Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US6015660A
(en)
*
|
1995-01-06 |
2000-01-18 |
The Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US5795966A
(en)
|
1995-02-22 |
1998-08-18 |
Immunex Corp |
Antagonists of interleukin-15
|
NZ311982A
(en)
|
1995-06-29 |
1999-08-30 |
Immunex Corp |
Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies
|
US7005505B1
(en)
|
1995-08-25 |
2006-02-28 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor
|
US6020473A
(en)
|
1995-08-25 |
2000-02-01 |
Genentech, Inc. |
Nucleic acids encoding variants of vascular endothelial cell growth factor
|
US6998116B1
(en)
|
1996-01-09 |
2006-02-14 |
Genentech, Inc. |
Apo-2 ligand
|
US6030945A
(en)
*
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
IL126383A0
(en)
|
1996-04-01 |
1999-05-09 |
Genentech Inc |
Apo-2li and apo-3 apoptosis polypeptides
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6462176B1
(en)
|
1996-09-23 |
2002-10-08 |
Genentech, Inc. |
Apo-3 polypeptide
|
US5990281A
(en)
*
|
1996-09-30 |
1999-11-23 |
Genentech, Inc. |
Vertebrate smoothened proteins
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
WO1998028424A2
(en)
|
1996-12-23 |
1998-07-02 |
Immunex Corporation |
Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
|
US6027630A
(en)
*
|
1997-04-04 |
2000-02-22 |
University Of Southern California |
Method for electrochemical fabrication
|
US6448035B1
(en)
|
1997-04-24 |
2002-09-10 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
|
US6384203B1
(en)
|
1999-05-12 |
2002-05-07 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
|
US6342369B1
(en)
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
JP2001523977A
(ja)
|
1997-06-05 |
2001-11-27 |
ザ ユニバーシティ オブ テキサス システム ボード オブ リージェンツ |
Apaf−1、ced−4ヒト相同体、カスパーゼ−3の活性化因子
|
EP1032661A1
(en)
|
1997-06-18 |
2000-09-06 |
Genentech, Inc. |
Apo-2DcR
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
DK1007546T3
(da)
|
1997-08-27 |
2009-03-16 |
Novartis Vaccines & Diagnostic |
Molekylære mimetika af meningokok-B-epitoper
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
JP4303883B2
(ja)
|
1997-09-18 |
2009-07-29 |
ジェネンテック・インコーポレーテッド |
DcR3ポリペプチドというTNFR相同体
|
WO1999019490A1
(en)
|
1997-10-10 |
1999-04-22 |
Genentech, Inc. |
Apo-3 ligand
|
EP2033970A3
(en)
|
1997-10-29 |
2009-06-17 |
Genentech, Inc. |
Polypeptides and nucleic acids encoding the same
|
IL135704A
(en)
|
1997-10-29 |
2008-04-13 |
Genentech Inc |
Method for the diagnosis of cancerous growth of cells by identifying the secreted polypeptide WISP-1 affected by WNT-1
|
CN101113436B
(zh)
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
ES2235378T3
(es)
|
1997-10-31 |
2005-07-01 |
The Board Of Regents Of The University Of Oklahoma |
Gen de la hialuronan sintasa y usos del mismo.
|
EP2278006A3
(en)
|
1997-11-06 |
2011-03-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
DE69840105D1
(de)
|
1997-11-21 |
2008-11-20 |
Genentech Inc |
Plättchen-spezifische antigene und deren pharmazeutische verwendung
|
SG152917A1
(en)
|
1998-01-14 |
2009-06-29 |
Chiron Srl |
Neisseria meningitidis antigens
|
ES2316182T3
(es)
|
1998-01-15 |
2009-04-01 |
Genentech, Inc. |
Ligando apo-2.
|
US6727079B1
(en)
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
EP2050762A3
(en)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Human cornichon-like protein and nucleic acids encoding it
|
JP4532733B2
(ja)
|
1998-03-17 |
2010-08-25 |
ジェネンテック, インコーポレイテッド |
Vegfおよびbmp1と相同なポリペプチド群
|
US20060188966A1
(en)
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
US7223571B2
(en)
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
US6987023B2
(en)
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP1944371B1
(en)
|
1998-05-01 |
2015-03-04 |
Novartis AG |
Neisseria meningitidis antigens and compositions
|
CA2328496C
(en)
|
1998-05-15 |
2016-01-05 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
JP4444506B2
(ja)
|
1998-08-21 |
2010-03-31 |
イミュネックス・コーポレーション |
ヒトil−1エプシロンdnaおよびポリペプチド
|
WO2000014265A1
(en)
|
1998-09-03 |
2000-03-16 |
Bristol-Myers Squibb Co. |
Enzymatic oxidative deamination process
|
JP2002527066A
(ja)
|
1998-10-15 |
2002-08-27 |
カイロン コーポレイション |
転移性乳癌および結腸癌調節遺伝子
|
US7094581B2
(en)
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
PT1141331E
(pt)
|
1998-12-16 |
2008-12-22 |
Novartis Vaccines & Diagnostic |
Quinase dependente de ciclina humana (hpnqalre)
|
EP1820859B9
(en)
|
1998-12-22 |
2009-10-28 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
EP2330198A1
(en)
|
1998-12-23 |
2011-06-08 |
Genentech, Inc. |
IL-1 related polypeptides
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
EP1978029A3
(en)
|
1999-06-15 |
2008-10-15 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids endoding the same
|
US7101989B1
(en)
|
1999-07-09 |
2006-09-05 |
University Of North Carolina At Chapel Hill |
DsrA protein and polynucleotides encoding the same
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
EP1305412A2
(en)
|
1999-10-14 |
2003-05-02 |
Clontech Laboratories Inc. |
Anthozoa derived chromo/fluoroproteins and methods for using the same
|
BR0015055A
(pt)
|
1999-10-20 |
2002-07-16 |
Genentech Inc |
Método de aumento estimulação ou potencialização da diferenciação de células t, método de tratamento de uma doença mediada por th1 em um mamìfero, método de prevenir, inibir ou atenuar a diferenciação de céluas t, método de tratamento de uma doença mediada por th2, em um mamìfero, método de determinação da presença de polipeptìdeo tccr em uma célula, método de diagnóstico de doenças mediadas por th1 ou mediadas por th2 em um mamìfero, método de identificação de compostos capazes de inibir a expressão de polipeptìdeos tccr e método para identificação de compostos capazes de inibir a atividade biológica de polipeptìdeo tccr, uso de antagonistas e agonistas de polipeptìdeos tccr
|
ES2564463T3
(es)
|
1999-10-29 |
2016-03-22 |
Glaxosmithkline Biologicals S.A. |
Péptidos antigénicos de Neisseriales
|
US7078382B1
(en)
|
1999-11-02 |
2006-07-18 |
Genentech, Inc. |
Modulation of eNOS activity and therapeutic uses thereof
|
EP2397031A1
(en)
|
1999-11-10 |
2011-12-21 |
The University Of Washington |
Compositions and methods for modulation of plant cell division
|
CA2490853A1
(en)
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU782067B2
(en)
|
1999-12-20 |
2005-06-30 |
Immunex Corporation |
TWEAK receptor
|
EP2290081A3
(en)
|
1999-12-23 |
2012-08-01 |
Genentech, Inc. |
IL-17 homologous polypeptide and therapeutic uses thereof
|
AU7476600A
(en)
|
1999-12-30 |
2001-07-16 |
Genencor International, Inc. |
Trichoderma reesei xylanase
|
ES2311016T3
(es)
|
2000-01-10 |
2009-02-01 |
Novartis Vaccines And Diagnostics, Inc. |
Genes expresados diferencialmente en cancer de mama.
|
PT1246917E
(pt)
|
2000-01-13 |
2009-06-02 |
Genentech Inc |
Polipéptidos stra6 humanos
|
WO2001052885A1
(en)
|
2000-01-17 |
2001-07-26 |
Chiron Spa |
Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
US7119085B2
(en)
|
2000-03-23 |
2006-10-10 |
Elan Pharmaceuticals, Inc. |
Methods to treat alzheimer's disease
|
EP2077276A1
(en)
|
2000-06-23 |
2009-07-08 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
|
EP2275549A1
(en)
|
2000-06-23 |
2011-01-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
JP2004502665A
(ja)
|
2000-06-30 |
2004-01-29 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
アルツハイマー病を治療する化合物
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
ATE412009T1
(de)
|
2000-08-24 |
2008-11-15 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
EP2189473A3
(en)
|
2000-10-27 |
2010-08-11 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic and proteins from streptococcus groups A & B
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
WO2002081642A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
AU2002303261A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
US7384775B2
(en)
|
2001-04-16 |
2008-06-10 |
Wyeth |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
ATE522623T1
(de)
|
2001-06-20 |
2011-09-15 |
Genentech Inc |
Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
|
US6867189B2
(en)
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
JP4592284B2
(ja)
|
2001-07-27 |
2010-12-01 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
髄膜炎菌付着因子
|
MY144532A
(en)
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
PL368972A1
(en)
|
2001-08-29 |
2005-04-04 |
Genentech, Inc. |
Bv8 nucleic acids and polypeptides with mitogenic activity
|
MXPA04002593A
(es)
|
2001-09-18 |
2004-05-31 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumor.
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
RU2330067C2
(ru)
|
2001-12-19 |
2008-07-27 |
Дзе Юниверсити Оф Чикаго |
Полинуклеотид, кодирующий хромо- или флуоресцирующий мутантный полипептид, вектор экспрессии, клетка, способ получения хромо- или флуоресцирующего полипептида, набор для получения хромо- или флуоресцирующего полипептида, применение полипептида и применение полинуклеотида
|
KR20080106369A
(ko)
|
2002-01-02 |
2008-12-04 |
제넨테크, 인크. |
종양의 진단 및 치료 방법 및 이를 위한 조성물
|
WO2003072035A2
(en)
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
EP1571968A4
(en)
|
2002-04-16 |
2007-10-17 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
|
WO2003099848A2
(en)
|
2002-05-24 |
2003-12-04 |
Restoragen Inc. |
Method for universal enzymatic production of bioactive peptides
|
AU2003243316A1
(en)
|
2002-05-24 |
2003-12-12 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
IL165392A0
(en)
|
2002-06-05 |
2006-01-15 |
Genentech Inc |
Compositions and methods for liver growth and liver protection
|
MXPA04012243A
(es)
|
2002-06-07 |
2005-02-25 |
Genentech Inc |
Composiciones y metodos para l diagnostico y tratamiento de tumores.
|
CA2489588A1
(en)
|
2002-07-08 |
2004-01-15 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
WO2004024068A2
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
CA2497334A1
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
US20070010434A1
(en)
|
2002-09-16 |
2007-01-11 |
Genetech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
WO2004028479A2
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
WO2004031376A2
(en)
|
2002-10-04 |
2004-04-15 |
Firmenich Sa |
Sesquiterpene synthases and methods of use
|
EP2322201A3
(en)
|
2002-10-29 |
2011-07-27 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP2006516094A
(ja)
|
2002-11-08 |
2006-06-22 |
ジェネンテック・インコーポレーテッド |
ナチュラルキラー細胞関連疾患の治療のための組成物と方法
|
CA2506318C
(en)
|
2002-11-15 |
2011-07-12 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
WO2004047728A2
(en)
|
2002-11-26 |
2004-06-10 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
AU2004219592C1
(en)
|
2003-03-12 |
2011-02-24 |
Genentech, Inc. |
Use of Bv8 and/or EG-VEGF to promote hematopoiesis
|
ES2609010T3
(es)
|
2003-04-04 |
2017-04-18 |
Genentech, Inc. |
Formulaciones de anticuerpos y de proteínas a concentración elevada
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
EP2392581A3
(en)
|
2003-04-25 |
2012-03-07 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
|
JP4866725B2
(ja)
|
2003-06-23 |
2012-02-01 |
ノース キャロライナ ステイト ユニヴァーシティー |
フラクトオリゴ糖利用化合物をコードするアシドフィルス菌核酸及びその使用
|
EP1641822B1
(en)
|
2003-07-08 |
2013-05-15 |
Genentech, Inc. |
Il-17 a/f heterologous polypeptides and therapeutic uses thereof
|
US7442785B2
(en)
|
2003-07-24 |
2008-10-28 |
The University Of Kentucky Research Foundation |
Sesquiterpene synthase gene and protein
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
WO2006101474A1
(en)
|
2005-03-15 |
2006-09-28 |
University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
EP1842920B2
(en)
|
2003-09-23 |
2017-06-21 |
University Of North Carolina At Chapel Hill |
Cells coexpressing vitamin K reductase and vitamin K dependent protein and use thereof to improve the productivity of said vitamin K dependent protein
|
JP4777251B2
(ja)
|
2003-10-14 |
2011-09-21 |
バクスター・インターナショナル・インコーポレイテッド |
ビタミンkエポキシド還元酵素複合体サブユニット1vkorc1、クマリンおよびその誘導体の治療標的
|
ES2493016T3
(es)
|
2003-11-17 |
2014-09-11 |
Genentech, Inc. |
Composiciones que comprenden anticuerpos contra CD79b conjugados a un agente inhibidor del crecimiento o un agente citotóxico y procedimientos para el tratamiento de tumores de origen hematopoyético
|
RS52246B
(en)
|
2003-11-21 |
2012-10-31 |
Nycomed Gmbh |
PROCEDURE FOR THE PRODUCTION OF PEPTIDE 2 LIKE GLUCAGON AND THEIR ANALOGS
|
WO2005074546A2
(en)
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human growth hormone polypeptides and their uses
|
US7459289B2
(en)
|
2004-03-08 |
2008-12-02 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
|
US8268324B2
(en)
|
2004-03-29 |
2012-09-18 |
Galpharma Co., Ltd. |
Modified galectin 9 proteins and use thereof
|
US7250298B2
(en)
|
2004-04-07 |
2007-07-31 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
WO2006009901A2
(en)
|
2004-06-18 |
2006-01-26 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
EP2298341A3
(en)
|
2004-10-21 |
2011-07-13 |
Wyeth LLC |
Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens
|
CA2592390A1
(en)
|
2004-12-22 |
2006-06-29 |
Genentech, Inc. |
Methods for producing soluble multi-membrane-spanning proteins
|
SG160437A1
(en)
|
2004-12-22 |
2010-04-29 |
Ambrx Inc |
Modified human growth hormone
|
SG158148A1
(en)
|
2004-12-22 |
2010-01-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
US7488848B2
(en)
|
2005-03-21 |
2009-02-10 |
Virobay, Inc. |
Alpha ketoamide compounds as cysteine protease inhibitors
|
EP2302032A1
(en)
|
2005-04-15 |
2011-03-30 |
North Carolina State University |
Methods and compositions to modulate adhesion and stress tolerance in bacteria
|
ES2361095T5
(es)
|
2005-05-04 |
2021-11-23 |
Zealand Pharma As |
Análogos del péptido 2 tipo glucagón (GLP-2)
|
EP2397493A1
(en)
|
2005-05-12 |
2011-12-21 |
ZymoGenetics, Inc. |
Compositions and methods for modulating immune responses
|
WO2006132788A2
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
CN101296613B
(zh)
|
2005-07-29 |
2016-02-10 |
目标栽培公司 |
显性失活突变体krp蛋白保护活性细胞周期蛋白-cdk复合物不受野生型krp抑制
|
CA2619577A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
EP3896076A1
(en)
|
2005-08-31 |
2021-10-20 |
The Regents of the University of California |
Cellular libraries of peptide sequences (clips) and methods of using the same
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
DE102005048898A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
DE602006018768D1
(de)
|
2005-10-18 |
2011-01-20 |
Nat Jewish Health Denver |
Konditionell immortalisierte adulte langzeit-stammzellen und verfahren zur herstellung und verwendung von solchen zellen
|
WO2007053732A2
(en)
|
2005-11-01 |
2007-05-10 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the blys gene and use in diagnostic methods
|
US20090018029A1
(en)
|
2005-11-16 |
2009-01-15 |
Ambrx, Inc. |
Methods and Compositions Comprising Non-Natural Amino Acids
|
EP2002714A1
(en)
|
2005-11-21 |
2008-12-17 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
US8026354B2
(en)
|
2005-11-23 |
2011-09-27 |
Institut Pasteur |
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
MY143274A
(en)
|
2005-12-22 |
2011-04-15 |
Genentech Inc |
Recombinant production of heparin binding proteins
|
ZA200807714B
(en)
|
2006-02-17 |
2010-01-27 |
Genentech Inc |
Gene disruptions, compositions and methods relating thereto
|
US20090288176A1
(en)
|
2006-04-19 |
2009-11-19 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
EP3026123A1
(en)
|
2006-04-27 |
2016-06-01 |
Klaritos, Inc. |
Method and kit for predicting antibody therapy
|
WO2008020335A2
(en)
|
2006-06-09 |
2008-02-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
AU2007269233B2
(en)
|
2006-06-30 |
2011-06-09 |
Cnj Holdings, Inc. |
Method of producing Factor VIII proteins by recombinant methods
|
EP2069396B1
(en)
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
MX2009004664A
(es)
|
2006-11-02 |
2009-10-12 |
Daniel J Capon |
Inmunoglobulinas hibridas con partes moviles.
|
DK2436781T3
(en)
|
2007-02-22 |
2016-01-11 |
Genentech Inc |
Methods for the detection of inflammatory bowel disease
|
WO2008121563A2
(en)
|
2007-03-30 |
2008-10-09 |
Ambrx, Inc. |
Modified fgf-21 polypeptides and their uses
|
DK2147116T3
(en)
|
2007-04-20 |
2016-05-30 |
Sigma Tau Rare Disease Ltd |
STABLE RECOMBINANT adenosine deaminase
|
CA2683423C
(en)
|
2007-04-26 |
2020-10-27 |
Inspiration Biopharmaceuticals, Inc. |
Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same
|
PE20140625A1
(es)
|
2007-07-16 |
2014-05-29 |
Genentech Inc |
ANTICUERPOS ANTI-CD79b E INMUNOCONJUGADOS HUMANIZADOS
|
CL2008002085A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
|
WO2009014726A1
(en)
|
2007-07-26 |
2009-01-29 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
WO2009046407A2
(en)
|
2007-10-04 |
2009-04-09 |
Zymogenetics, Inc. |
B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
|
US20090233991A1
(en)
|
2007-11-01 |
2009-09-17 |
Hee Cheol Cho |
Generation of biological pacemaker activity
|
US8679749B2
(en)
|
2007-11-01 |
2014-03-25 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
EP2930182A1
(en)
|
2007-11-20 |
2015-10-14 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
WO2009070648A2
(en)
|
2007-11-27 |
2009-06-04 |
Medtronic, Inc. |
Humanized anti-amyloid beta antibodies
|
WO2009073511A2
(en)
|
2007-11-30 |
2009-06-11 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the blys gene and use in diagnostic methods
|
ES2643239T3
(es)
|
2008-01-31 |
2017-11-21 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
CA2712606A1
(en)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
WO2009104097A2
(en)
|
2008-02-21 |
2009-08-27 |
Novartis Ag |
Meningococcal fhbp polypeptides
|
JP5770624B2
(ja)
|
2008-04-09 |
2015-08-26 |
ジェネンテック, インコーポレイテッド |
免疫関連疾患の治療のための新規組成物と方法
|
SG190661A1
(en)
|
2008-05-16 |
2013-06-28 |
Taiga Biotechnologies Inc |
Antibodies and processes for preparing the same
|
AU2009274076C1
(en)
|
2008-07-23 |
2014-04-17 |
Ambrx, Inc. |
Modified bovine G-CSF polypeptides and their uses
|
SG193831A1
(en)
|
2008-08-28 |
2013-10-30 |
Taiga Biotechnologies Inc |
Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
|
KR101732054B1
(ko)
|
2008-09-26 |
2017-05-02 |
암브룩스, 인코포레이티드 |
비천연 아미노산 복제 의존성 미생물 및 백신
|
EA019653B1
(ru)
|
2008-09-26 |
2014-05-30 |
Амбркс Инк. |
Модифицированные полипептиды эритропоэтина животных и их применение
|
US9702877B2
(en)
|
2008-10-31 |
2017-07-11 |
Quest Diagnostics Investments Incorporated |
BCR-ABL variants
|
AU2009319772A1
(en)
|
2008-11-26 |
2010-06-03 |
Centocor Research & Development, Inc. |
Compositions and methods for regulating collagen and smooth muscle actin expression by SERPINE2
|
MX362028B
(es)
|
2009-02-03 |
2019-01-04 |
Amunix Pharmaceuticals Inc |
Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
|
CA2757382A1
(en)
|
2009-04-01 |
2010-10-21 |
Kristi Elkins |
Anti-fcrh5 antibodies and immunoconjugates
|
EP2251025A1
(en)
|
2009-05-12 |
2010-11-17 |
Universitat Autònoma De Barcelona |
Use of inclusion bodies as therapeutic agents
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
WO2010144502A2
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
NZ597458A
(en)
|
2009-07-03 |
2014-01-31 |
Bionor Immuno As |
Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
|
CA2772051C
(en)
|
2009-08-24 |
2020-08-18 |
Amunix Operating Inc. |
Coagulation factor ix compositions and methods of making and using same
|
EP3017828A1
(en)
|
2009-08-27 |
2016-05-11 |
GlaxoSmithKline Biologicals SA |
Hybrid polypeptides including meningococcal fhbp sequences
|
US9488656B2
(en)
|
2009-09-30 |
2016-11-08 |
Quest Diagnostics Investments Incorporated |
BCR-ABL truncation mutations
|
EP2486131A1
(en)
|
2009-10-06 |
2012-08-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Carbapenemase and antibacterial treatment
|
MX368790B
(es)
|
2009-10-15 |
2019-10-16 |
Genentech Inc |
Factores de crecimiento de fibroblasto quimericos con especificidad de receptor alterada.
|
EP2490718B1
(en)
|
2009-10-22 |
2016-01-13 |
F.Hoffmann-La Roche Ag |
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
US20130022633A1
(en)
|
2009-10-27 |
2013-01-24 |
University Of Florence |
MENINGOCOCCAL fHBP POLYPEPTIDES
|
US20110110942A1
(en)
|
2009-11-12 |
2011-05-12 |
Genentech, Inc. |
Method of promoting dendritic spine density
|
CN102741294A
(zh)
|
2009-11-30 |
2012-10-17 |
霍夫曼-拉罗奇有限公司 |
治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
|
AU2010341516B2
(en)
|
2009-12-21 |
2014-01-16 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
US20120283172A1
(en)
|
2009-12-21 |
2012-11-08 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
FR2954349A1
(fr)
|
2009-12-22 |
2011-06-24 |
Agronomique Inst Nat Rech |
Sulfatase modifiant selectivement les glycosaminoglycanes
|
BR112012020373A8
(pt)
|
2010-02-23 |
2018-01-02 |
Genentech Inc |
anticorpo isolado, célula, ácido nucleico isolado, método de identificação, de inibição da proliferação de uma célula, de tratamento terapêutico, de determinação da presença de uma proteína tat419, de diagnóstico da presença de câncer e de distribuição de agente citotóxico
|
EP3372617B1
(en)
|
2010-04-02 |
2024-07-24 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
WO2011139985A1
(en)
|
2010-05-03 |
2011-11-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US9040302B2
(en)
|
2010-05-19 |
2015-05-26 |
North Carolina State University |
Genetically modified Streptococcus thermophilus bacterium
|
WO2011149461A1
(en)
|
2010-05-27 |
2011-12-01 |
Medtronic, Inc. |
Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
|
CN103037887B
(zh)
|
2010-06-25 |
2017-11-10 |
国家医疗保健研究所 |
用于治疗呼吸道感染的方法和药物组合物
|
DK2598526T3
(en)
|
2010-07-29 |
2018-11-19 |
Eleven Biotherapeutics Inc |
CHEMICAL IL-1 RECEPTOR TYPE-I AGONISTS AND ANTAGONISTS
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
WO2012024452A2
(en)
|
2010-08-17 |
2012-02-23 |
Ambrx, Inc. |
Modified relaxin polypeptides and their uses
|
EP2420253A1
(en)
|
2010-08-20 |
2012-02-22 |
Leadartis, S.L. |
Engineering multifunctional and multivalent molecules with collagen XV trimerization domain
|
US8729233B2
(en)
|
2010-08-30 |
2014-05-20 |
Board Of Trustees Of Michigan State University |
Microbial nanowires and products related thereto
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
CA2811403A1
(en)
|
2010-09-15 |
2012-03-22 |
Aligna Technologies, Inc. |
Bioproduction of aromatic chemicals from lignin-derived compounds
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
EP2441776A1
(en)
|
2010-10-15 |
2012-04-18 |
Leadartis, S.L. |
Generation of multifunctional and multivalent polypeptide complexes with collagen XVIII trimerization domain
|
EP2646465B1
(en)
|
2010-10-15 |
2018-09-12 |
Leadartis, S.L. |
Generation of multifunctional and multivalent polypeptide complexes with collagen xviii trimerization domain
|
EP2655607A4
(en)
|
2010-12-21 |
2014-05-14 |
Univ North Carolina |
METHOD AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS
|
US8603740B2
(en)
|
2010-12-29 |
2013-12-10 |
Quest Diagnostics Investments Incorporated |
BCR-ABL1 splice variants and uses thereof
|
WO2012095684A1
(en)
|
2011-01-10 |
2012-07-19 |
Inserm ( Institut National De La Sante Et De La Recherche Medicale) |
Methods for the screening of substances useful for the prevention and treatment of neisseria infections
|
WO2012103240A2
(en)
|
2011-01-25 |
2012-08-02 |
Eleven Biotherapeutics, Inc. |
Receptor binding agents
|
CN103533951B
(zh)
|
2011-04-08 |
2017-04-19 |
安姆根有限公司 |
使用生长分化因子15(gdf‑15)治疗或改善代谢障碍的方法
|
WO2013011072A1
(en)
|
2011-07-20 |
2013-01-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Carbapenemase and antibacterial treatment
|
BR112014002173A2
(pt)
|
2011-07-29 |
2017-03-01 |
Eleven Biotherapeutics Inc |
proteínas purificadas
|
WO2013033456A2
(en)
|
2011-09-02 |
2013-03-07 |
Board Of Trustees Of Michigan State University |
Microbial nanowires and methods of making and using
|
EA201491413A1
(ru)
|
2012-01-26 |
2015-03-31 |
Эмджен Инк. |
Полипептиды фактора роста и дифференцировки 15 (gdf-15)
|
EA201491470A1
(ru)
|
2012-02-15 |
2015-01-30 |
Амуникс Оперэйтинг Инк. |
Композиции фактора viii и способы получения и использования подобных
|
NZ628014A
(en)
|
2012-02-15 |
2016-09-30 |
Biogen Ma Inc |
Recombinant factor viii proteins
|
EA037979B1
(ru)
|
2012-02-27 |
2021-06-18 |
Амуникс Оперейтинг Инк. |
Композиции конъюгата xten и способы их получения
|
AR090340A1
(es)
|
2012-03-27 |
2014-11-05 |
Genentech Inc |
Operaciones de cosecha mejoradas para proteinas recombinadas
|
EP2841087B1
(en)
|
2012-04-27 |
2017-08-23 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Vascular endothelial growth factor antagonists and methods for their use
|
EA028929B1
(ru)
|
2012-05-03 |
2018-01-31 |
Зилэнд Фарма А/С |
Аналоги глюкагоноподобного пептида-2 (glp-2)
|
JP2015520179A
(ja)
|
2012-06-06 |
2015-07-16 |
ビオノール イミュノ エーエスBionor Immuno As |
ワクチン
|
SG11201500429QA
(en)
|
2012-07-20 |
2015-03-30 |
Taiga Biotechnologies Inc |
Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
|
US9309510B2
(en)
|
2012-08-10 |
2016-04-12 |
Cytomx Therapeutics, Inc. |
Protease-resistant systems for polypeptide display and methods of making and using thereof
|
WO2014081831A1
(en)
|
2012-11-20 |
2014-05-30 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for modified factor ix proteins
|
WO2014088940A1
(en)
|
2012-12-07 |
2014-06-12 |
Danisco Us Inc. |
Compositions and methods of use
|
CA2891504A1
(en)
|
2012-12-07 |
2014-06-12 |
Danisco Us Inc. |
Compositions and methods of use
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
CN107693781B
(zh)
|
2013-03-13 |
2021-11-09 |
巴扎德制药公司 |
用于眼部递送的嵌合细胞因子制剂
|
WO2014145016A2
(en)
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
EP4039281A1
(en)
|
2013-03-15 |
2022-08-10 |
Biomolecular Holdings LLC |
Hybrid immunoglobulin containing non-peptidyl linkage
|
WO2015007337A1
(en)
|
2013-07-19 |
2015-01-22 |
Bionor Immuno As |
Method for the vaccination against hiv
|
TWI667255B
(zh)
|
2013-08-14 |
2019-08-01 |
美商生物化學醫療公司 |
因子viii-xten融合物及其用途
|
EP3060656A1
(en)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using same
|
MX2016005614A
(es)
|
2013-11-01 |
2016-12-09 |
Spherium Biomed S L |
Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
ES2788973T3
(es)
|
2014-03-14 |
2020-10-23 |
Biomolecular Holdings Llc |
Inmunoglobulina híbrida que contiene una unión distinta de peptidilo
|
EP3166633A1
(en)
|
2014-07-11 |
2017-05-17 |
Bionor Immuno AS |
Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
|
WO2016054185A1
(en)
|
2014-09-30 |
2016-04-07 |
Danisco Us Inc |
Compositions comprising beta-mannanase and methods of use
|
WO2016054194A1
(en)
|
2014-09-30 |
2016-04-07 |
1/1Danisco Us Inc |
Compositions comprising beta-mannanase and methods of use
|
EP3201330A1
(en)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Compositions comprising beta mannanase and methods of use
|
EP3201331A1
(en)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Compositions comprising beta mannanase and methods of use
|
EP3201332A1
(en)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Compositions comprising beta-mannanase and methods of use
|
EP3909596A1
(en)
|
2014-10-24 |
2021-11-17 |
Bristol-Myers Squibb Company |
Modified fgf-21 polypeptides and uses thereof
|
EP3234118A1
(en)
|
2014-12-18 |
2017-10-25 |
Danisco US Inc. |
Engineered multifunctional enzymes and methods of use
|
US20170362621A1
(en)
|
2014-12-18 |
2017-12-21 |
Danisco Us Inc. |
Engineered multifunctional enzymes and methods of use
|
AU2016215124B2
(en)
|
2015-02-06 |
2020-08-06 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting Factor VIII gene expression cassettes and their use
|
AU2016239683B2
(en)
|
2015-03-31 |
2022-02-03 |
Novimmune Sa |
Method for optimizing the assembly and production of hetero-multimeric protein complexes
|
US20180140694A1
(en)
|
2015-05-04 |
2018-05-24 |
Bionor Immuno As |
Dosage regimen for hiv vaccine
|
AU2016301303B2
(en)
|
2015-08-03 |
2021-10-07 |
Bioverativ Therapeutics Inc. |
Factor IX fusion proteins and methods of making and using same
|
MX2018002226A
(es)
|
2015-08-28 |
2018-03-23 |
Amunix Operating Inc |
Ensamble de polipeptido quimerico y metodos para hacer y usar el mismo.
|
CA3019373A1
(en)
|
2016-03-29 |
2017-10-05 |
Geltor, Inc. |
Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1
|
US11510966B2
(en)
|
2016-04-15 |
2022-11-29 |
Evive Biotechnology (Shanghai) Ltd |
Use of IL-22 in treating necrotizing enterocolitis
|
US10590426B2
(en)
|
2016-08-22 |
2020-03-17 |
Board Of Trustees Of Michigan State University |
Genetic control of cell size
|
EP3548425B1
(en)
|
2016-12-02 |
2023-03-29 |
Taiga Biotechnologies, Inc. |
Nanoparticle formulations
|
EP4295840A3
(en)
|
2016-12-06 |
2024-03-13 |
DSM Nutritional Products, LLC |
Glycan polymers and related methods thereof
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
BR112019016139A2
(pt)
|
2017-02-08 |
2020-04-07 |
Bristol-Myers Squibb Company |
polipeptídio de relaxina modificada compreendendo um melhorador farmacocinético e usos do mesmo
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
EP3490584B1
(en)
|
2017-08-03 |
2021-12-08 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
US11180541B2
(en)
|
2017-09-28 |
2021-11-23 |
Geltor, Inc. |
Recombinant collagen and elastin molecules and uses thereof
|
SG11202006259SA
(en)
|
2018-01-26 |
2020-08-28 |
Genentech Inc |
Il-22 fc fusion proteins and methods of use
|
RS63812B1
(sr)
|
2018-01-26 |
2023-01-31 |
Hoffmann La Roche |
Il-22 fc kompozicije i postupci primene
|
KR20200123118A
(ko)
|
2018-02-21 |
2020-10-28 |
제넨테크, 인크. |
IL-22 Fc 융합 단백질로 치료를 위한 투약
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
BR112020020823A2
(pt)
|
2018-04-09 |
2021-01-19 |
Amgen Inc. |
Proteínas de fusão do fator de diferenciação do crescimento 15
|
MA52630A
(fr)
|
2018-05-18 |
2021-05-26 |
Bioverativ Therapeutics Inc |
Procédés de traitement de l'hémophilie a
|
JP2021525537A
(ja)
|
2018-06-06 |
2021-09-27 |
レアダルティス、ソシエダッド リミターダLeadartis, S.L. |
三量体ポリペプチド複合体およびその使用
|
LT3849614T
(lt)
|
2018-09-11 |
2024-03-25 |
Ambrx, Inc. |
Interleukino-2 polipeptido konjugatai ir jų panaudojimas
|
US20220175807A1
(en)
|
2019-03-31 |
2022-06-09 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
TW202104254A
(zh)
|
2019-04-12 |
2021-02-01 |
美商格爾托公司 |
重組彈性蛋白及其生產
|
KR102134418B1
(ko)
*
|
2019-06-17 |
2020-07-16 |
씨제이제일제당 주식회사 |
L-타이로신을 생산하는 미생물 및 이를 이용한 l-타이로신 생산 방법
|
JP2023517595A
(ja)
|
2020-03-11 |
2023-04-26 |
アンブルックス,インコーポレイテッド |
インターロイキン-2ポリペプチド結合物およびその使用方法
|
WO2021207662A1
(en)
|
2020-04-10 |
2021-10-14 |
Genentech, Inc. |
Use of il-22fc for the treatment or prevention of pneumonia, acute respiratory distress syndrome, or cytokine release syndrome
|
IL288680A
(en)
|
2021-12-05 |
2023-07-01 |
Yeda Res & Dev |
Genetically modified phages and their use
|
WO2024133316A1
(en)
|
2022-12-23 |
2024-06-27 |
Thermo Fisher Scientific Baltics Uab |
Closed system for expressing recombinant proteins using e. coli and methods for producing clarified cell cultures thereof
|